1. Prognostic significance of mutant IDH1, CD133, and β-catenin immunohistochemical expression in glioblastoma multiforme
   Azza Abdel-Aziz et al, 2018, Egyptian Journal of Pathology CrossRef
2. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
   Thomas Joyce et al, 2023, Current Oncology CrossRef
3. Targeting Glioma Stem Cells
   Yagmur Muftuoglu et al, 2021, Neurosurgery Clinics of North America CrossRef
4. A2B5 Expression in Central Nervous System and Gliomas
   Dominique Figarella-Branger et al, 2022, International Journal of Molecular Sciences CrossRef
5. Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene
   Xiaofeng Wang et al, 2016, Oncology Letters CrossRef
6. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis
   Chen Li et al, 2016, Journal of Molecular Neuroscience CrossRef
7. Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
   null Baeza-Kallee et al, 2019, Cancers CrossRef
8. Replacement of the Trabecular Meshwork Cells—A Way Ahead in IOP Control?
   Xiaochen Fan et al, 2021, Biomolecules CrossRef
9. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review
   Azadeh Fakhrioliaei et al, 2024, The Journal of Membrane Biology CrossRef
10. Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
    Henry Ruiz-Garcia et al, 2020, Frontiers in Cellular Neuroscience CrossRef
11. Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma
    Cristiana Angelucci et al, 2021, International Journal of Molecular Sciences CrossRef
12. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration
    Yasmin Ghochani et al, 2022, Cell Reports CrossRef